SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-088453
Filing Date
2024-04-05
Accepted
2024-04-05 16:06:49
Documents
5
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d769371ddef14a.htm DEF 14A 389389
2 GRAPHIC g769371g46v87.jpg GRAPHIC 1599
3 GRAPHIC g769371g98g92.jpg GRAPHIC 7431
4 GRAPHIC g769371g99v90.jpg GRAPHIC 8172
5 GRAPHIC g769371pc2aa.jpg GRAPHIC 1393
  Complete submission text file 0001193125-24-088453.txt   416700
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38997 | Film No.: 24826512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)